Examine the role of AB-PMJAY's package-rate mechanism in moderating private hospital costs. What are its limitations?

Ayushman Bharat–PMJAY fixes pre-negotiated Health Benefit Packages (HBPs) — around 1,900 listed procedures priced uniformly for empanelled public and private hospitals [1]. It is India's largest experiment in administered pricing of hospital care, and it moderates private costs only within the boundary it draws.

How the mechanism moderates costs

• Administered uniform rates: an empanelled corporate hospital is paid the same rate as a district hospital for a listed procedure, removing discretionary pricing for scheme beneficiaries [1].
• Cashless, bundled billing covers implants, drugs and diagnostics within one package price, curbing surprise add-on bills and out-of-pocket (OOP) outgo [1].
• Periodic rate revision — NHA has repeatedly raised package rates, including sharp revisions for ICU and ventilator care — keeping private participation viable without passing costs to patients [2].
• Differential pricing by city tier and level of care, introduced with HBP 2022, adapts rates to input costs instead of forcing exit [1].
• Quality-linked incentives: Gold/Silver/Bronze certified hospitals earn 15%, 10% and 5% higher rates, tying price to standards rather than bargaining power [3].

Limitations

• Scope: rates bind only empanelled hospitals for listed inpatient procedures; OPD care, diagnostics and outpatient medicines — the bulk of OOP spending — stay unregulated.
• Beneficiary limits: cover targets the poorest and elderly; the "missing middle" pays market rates, prompting the 176th Report of the Parliamentary Standing Committee on Health (tabled 7 August 2026) to urge low-cost insurance for middle-income households [4].
• Persisting divide: average hospitalisation still costs ₹50,508 privately against ₹6,631 in government facilities, showing the scheme has not disciplined general private pricing [4]; private hospitals already handle over half of hospitalisations [5].
• Rate adequacy disputes reduce willingness to empanel, which is why the Committee proposed incentivised PPPs in non-urban areas [4].
• Federal enforcement: health is a State subject, so price discipline beyond empanelment needs State machinery.

The mechanism is therefore a partial, contractual price floor rather than genuine regulation. Extending it demands the Committee's proposed statutory national price-fixation body, mandatory pre-treatment cost estimates, and higher public health spending — moving India closer to the universal, affordable care promised by Article 47 and SDG-3.